Publication

Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube.

Griffiths, Richard W
; 
Zee, Ying-Kiat
; 
Evans, Saran
; 
Mitchell, Claire L
; 
Kumaran, Gireesh C
; 
Welch, Richard
; ; 
Clamp, Andrew R
; 
Hasan, Jurjees
Citations
Altmetric:
Abstract
: Platinum-resistant and refractory cancers of the ovary, fallopian tube, and peritoneum have a poor prognosis, yet in some cases, they can respond to multiple lines of chemotherapy. Uncertainty remains over optimal drug choice and when therapeutic focus should be switched from active therapy to supportive care.
Authors
Griffiths, Richard W
Zee, Ying-Kiat
Evans, Saran
Mitchell, Claire L
Kumaran, Gireesh C
Welch, Richard
Jayson, Gordon C
Clamp, Andrew R
Hasan, Jurjees
Affiliation
Departments of *Medical Oncology, and †Clinical Oncology, The Christie NHS Foundation Trust; and ‡School of Cancer and Enabling Science, University of Manchester, Manchester, UK.
Description
Date
2011-01
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Ovarian Cancer
Chemotherapy
Fallopian Tube Cancer
Treatment Resistance
Type
Article
Citation
Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube. 2011, 21 (1):58-65 Int. J Gynecol Cancer
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/120281
Embedded videos